Immuneed is a brand that offers a tailored solution in the early stages of development, enabling the creation of safe and effective drugs. With a great team driven to become the number one in the industry, Immuneed combines strong scientific knowledge with a versatile preclinical platform based on fresh, circulating human blood. This innovative approach allows them to provide their customers with personalized solutions that meet their specific needs.

Founded in 2014, Immuneed initially focused on developing a novel immunotherapy for cancer. As the evaluation of this therapy became more complex, they developed a proprietary platform to characterize drugs and predict outcomes in a clinical setting. This platform reduces the need for animal studies and provides early indications of the drug's effectiveness in humans.

Today, Immuneed is fully dedicated to advancing their platform and associated services, benefiting biotech and pharmaceutical companies globally. By addressing critical questions about drug safety and immunology, Immuneed is able to cut costs for their customers and add value to drug development projects. Contact Immuneed today to find out how their exceptional services can benefit your drug development journey